A Study of PROQOL (Patient Reported Outcome Quality of Life) Tool in the Hematology and Oncology Population

Overview

Sponsor Protocol Number: 15-008231

About this study

The purpose of this study is to assess if the electronic patient reported outcome quality of life (PROQOL) tool will be beneficial to hematology and oncology patients, helping to improve their quality of life by communicating symptoms and needs to busy clinicians.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Has a hematologic or solid malignancy
  • Follow-up care provided at the Mayo Clinic, Rochester for either treatment
  • At least 18 years or older
  • Ability to sign consent
  • Ability to use the iPad to complete the tool, and answer a post tool survey

More information

Publications

Publications are currently not available
.
CLS-20304025

Mayo Clinic Footer